We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$46.4B
AUM Growth
+$701M
(+1.5%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
14.53%
Holding
2,237
New
170
Increased
888
Reduced
909
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$197M |
| 2 |
Deckers Outdoor
DECK
|
+$179M |
| 3 |
DexCom
DXCM
|
+$156M |
| 4 |
Teradyne
TER
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$163M |
| 2 |
Wingstop
WING
|
+$130M |
| 3 |
ServiceNow
NOW
|
+$108M |
| 4 |
GoDaddy
GDDY
|
+$94.2M |
| 5 |
Vertiv
VRT
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Cousins Properties
CUZ
$4.65B
| $2.32M | 0.01% |
78,764
-3,456
| -4% | -$103K |
|
902
Forrester Research
FORR
$221M
| $2.31M | 0.01% |
250,364
+150,265
| +150% | +$1.91M |
|
903
Krystal Biotech
KRYS
$9.97B
| $2.3M | 0.01% |
12,781
-267
| -2% | -$44.9K |
|
904
Hanover Insurance
THG
$8.07B
| $2.3M | 0.01% |
13,242
+211
| +2% | +$34.2K |
|
905
Minerva Neurosciences
NERV
$166M
| $2.3M | 0.01% |
1,351,275
| – | – |
|
906
Suburban Propane Partners
SPH
$1.13B
| $2.29M | ﹤0.01% |
109,046
| – | – |
|
907
Amneal Pharmaceuticals
AMRX
$6.3B
| $2.29M | ﹤0.01% |
273,071
+1,237
| +0.5% | +$10.3K |
|
|
CTLP
908
DELISTED
Cantaloupe
CTLP
| $2.29M | ﹤0.01% |
290,684
-15,915
| -5% | -$141K |
|
909
Crane NXT
CXT
$2.72B
| $2.28M | ﹤0.01% |
44,316
+13,536
| +44% | +$793K |
|
910
Lear
LEA
$6.08B
| $2.26M | ﹤0.01% |
25,645
-280
| -1% | -$26.6K |
|
911
Arteris
AIP
$1.03B
| $2.26M | ﹤0.01% |
327,119
+161,241
| +97% | +$1.54M |
|
912
Stagwell
STGW
$2.04B
| $2.26M | ﹤0.01% |
373,527
| – | – |
|
913
Mueller Industries
MLI
$13.4B
| $2.2M | ﹤0.01% |
57,698
+34,156
| +145% | +$1.36M |
|
914
Zymeworks
ZYME
$1.88B
| $2.17M | ﹤0.01% |
181,912
+286
| +0.2% | +$3.9K |
|
915
Southwest Gas
SWX
$6.28B
| $2.17M | ﹤0.01% |
30,165
+72
| +0.2% | +$5.33K |
|
916
CACI
CACI
$13.9B
| $2.16M | ﹤0.01% |
5,891
-548
| -9% | -$210K |
|
917
Peoples Bancorp
PEBO
$1.42B
| $2.15M | ﹤0.01% |
72,548
-359
| -0.5% | -$11.3K |
|
918
Tapestry
TPR
$23.5B
| $2.14M | ﹤0.01% |
30,336
+29,634
| +4,221% | +$2.24M |
|
919
AbCellera Biologics
ABCL
$3.78B
| $2.11M | ﹤0.01% |
947,751
+31,514
| +3% | +$90.4K |
|
920
MP Materials
MP
$8.73B
| $2.1M | ﹤0.01% |
86,167
-1,414
| -2% | -$32.9K |
|
921
Dolby
DLB
$5.5B
| $2.1M | ﹤0.01% |
26,095
+1,618
| +7% | +$132K |
|
922
WD-40
WDFC
$2.55B
| $2.07M | ﹤0.01% |
8,493
-4,450
| -34% | -$1.05M |
|
|
INR
923
Infinity Natural Resources
INR
$247M
| $2.04M | ﹤0.01% |
+108,858
| New | +$2.04M |
|
924
Vanguard Morningstar Total Stock Market ETF
VTI
$678B
| $2.03M | ﹤0.01% |
7,403
+118
| +2% | +$34.3K |
|
925
Gates Industrial Corp
GTES
$6.44B
| $2.03M | ﹤0.01% |
110,312
-38,182
| -26% | -$787K |
|
Similar funds
Federated Hermes's Q1 2025 Portfolio in Review
As of Q1 2025, Federated Hermes held 2,237 positions worth $46.4B, up 1.5% from $45.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.34B of net new capital in Q1 2025, opening 170 new positions and adding to 888 existing holdings. Its largest new stake was Zscaler: 283,095 shares worth $56.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $163M trimmed.
- Federated Hermes's largest Q1 2025 buy was Zscaler: 283,095 shares worth $56.2M.
- Federated Hermes added most to Amgen in Q1 2025, an estimated $197M increase.
- Federated Hermes's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $163M.
- Federated Hermes fully exited New Fortress Energy in Q1 2025, selling an estimated $31.4M.
- Federated Hermes's ten largest holdings make up 15% of its $46.4B portfolio in Q1 2025.
- Federated Hermes opened 170 new positions and closed 187 in Q1 2025.
- Federated Hermes's portfolio value rose 1.5% quarter-over-quarter to $46.4B.
Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.